Edition:
India

Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

26.62USD
15 Dec 2017
Change (% chg)

$0.36 (+1.37%)
Prev Close
$26.26
Open
$26.58
Day's High
$27.35
Day's Low
$26.58
Volume
652,915
Avg. Vol
75,403
52-wk High
$27.35
52-wk Low
$7.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.43 December 18 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 5 3.30 16.19 0.00 --
Quarter Ending Mar-18 1 13.00 13.00 13.00 --
Year Ending Dec-17 3 149.35 160.07 143.90 19.16
Year Ending Dec-18 4 7.36 16.00 0.19 78.96
Earnings (per share)
Quarter Ending Dec-17 5 -0.43 0.17 -0.65 --
Quarter Ending Mar-18 2 -0.67 -0.66 -0.67 --
Year Ending Dec-17 3 4.00 4.55 3.64 -2.08
Year Ending Dec-18 5 -2.46 -2.31 -2.64 -1.25

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.01 143.84 143.83 1,229,335.88
Quarter Ending Jun-17 0.05 0.01 0.04 70.00
Quarter Ending Mar-17 0.00 0.02 0.02 0.00
Quarter Ending Dec-16 1.77 0.02 1.75 98.81
Quarter Ending Sep-16 0.42 0.03 0.39 93.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3.30 3.30 3.30 0.04 --
Quarter Ending Mar-18 13.00 13.00 13.00 -- --
Year Ending Dec-17 149.35 149.35 149.35 0.12 19.16
Year Ending Dec-18 7.36 7.36 7.36 5.48 78.96

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings